Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration

Manhapra, Ajay; L. Petrakis, Ismene; A. Rosenheck, Robert

doi:10.1111/ajad.12553

Public

Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration

Published in American Journal on Addictions • May 4, 2017

Authors:

Ajay Manhapra

Ismene L. Petrakis

Robert A. Rosenheck

Abstract

BACKGROUND: Buprenorphine has become the major treatment for opioid use disorder (OUD) but data on long treatment term retention and its correlates are sparse. METHODS: All veterans with OUD treated in Veterans Health Administration (VHA) facilities nationally in fiscal year (FY) 2012, and who began...

Subject

Buprenorphine

Medicine

Discontinuation

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!